EcoDrugPlus

Insulin Receptor-Like

Ensembl ID : ENSBSLG00000008798
Gene Symbol: LOC114854523
3 Cross references
201 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSBSLG00000023039
Gene Symbol: LOC114852027
3 Cross references
204 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSBSLG00000012889
Gene Symbol: LOC114860744
3 Cross references
204 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSBSLG00000009772
Gene Symbol: ITGA4
3 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSBSLG00000011343
Gene Symbol: ITGA5
3 Cross references
206 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSBSLG00000005476
Gene Symbol: ITGA5
3 Cross references
196 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSBSLG00000008169
Gene Symbol: ITGAV
3 Cross references
238 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSBSLG00000025154
Gene Symbol: ITGB1
3 Cross references
230 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSBSLG00000018863
Gene Symbol: ITGB3
3 Cross references
195 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSBSLG00000025617
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSBSLG00000014262
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSBSLG00000013126
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).